<unk>  is used for the treatment of a number of cancer types in children. In the US, it is approved for the second-line therapy of acute lymphocytic leukemia (ALL) in combination with other antineoplastic drugs. In Europe, it is also approved for the treatment of Hodgkin's lymphoma, generalized malignant lymphoma, reticulocyte sarcoma, acute leukaemia, primary brain tumours (glioblastoma, ependymoma, astrocytoma), bladder cancer, neuroblastoma and other solid tumours in children. Administration The medication is injected though a vein and burns if it leaks under the skin. It can be used in combination with other anticancer drugs.
Teniposide
Voglibose
Avalglucosidase alfa
Ellagic acid
Liranaftate
Alglucosidase alfa
Glucuronide
Icodextrin